financetom
Business
financetom
/
Business
/
What's Going On With Greenlane Holdings Stock Tuesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Greenlane Holdings Stock Tuesday?
Aug 13, 2024 6:53 AM

Greenlane Holdings Inc ( GNLN ) shares are trading lower Tuesday, pulling back after rallying more than 365% on Monday. Here’s a look at what you need to know.

What To Know: Greenlane ( GNLN ) shares surged on Monday after the company announced that it entered into a non-binding letter of intent (LOI) to be the exclusive distributor of Safety Strips in the U.S.

Safety Strips offers fentanyl, xylazine and drink spike detection test strips. To use the test, a small sample of the substance is mixed with water. The test strip is then dipped into the liquid for 15 seconds. After waiting approximately five minutes, the results can be read, offering a quick way to identify the presence of dangerous adulterants. 

“We are excited and proud to provide Safety Strips affordable and highly accurate tests with trace level fentanyl and xylazine detection capabilities to our customers throughout the U.S.,” said Barbara Sher, CEO of Greenlane ( GNLN ).

“Safety Strips products are an innovative and complementary addition to our extensive product portfolio, and we plan to leverage our strong distribution, operations, marketing and sales teams to support the brand.”

Shortly after shares soared on the announcement, Greenlane ( GNLN ) said it entered into a securities purchase agreement with an institutional investor for aggregate gross cash proceeds of $6.5 million. In connection with the private placement, the company will issue an aggregate of 2,363,637 units and pre-funded units. Each unit will consist of one share of common stock and two common warrants.

See Also: Producer Prices Slow More Than Expected In July, Bolster Fed Rate Cut Wagers

Tuesday morning, Greenlane ( GNLN ) highlighted recent stock purchases from its CEO. The company announced in a press release that Sher acquired 12,500 common shares of Greenlane ( GNLN ) in the open market between Aug. 5 and Aug. 9 at an average price of $2.66 per share.

“The purchase of Common Shares by the Chief Executive Officer of the Company reflects confidence in the intrinsic value of the stock and the near-term and long-term growth prospects of the Company,” the company said.

It’s worth noting that Greenlane ( GNLN ) effected a one-for-11 reverse stock split on Aug. 5. The stock began trading on a post-split basis that day. The stock also appears to be seeing increased attention from retail investors. According to Benzinga Pro, 19.41% of the company’s float is currently being sold short.

GNLN Price Action: Greenlane ( GNLN ) shares were down 14.2% at $9.87 at the time of publication, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lattice Semiconductor Q3 Adjusted Earnings, Revenue Rise; Q4 Outlook Set
Lattice Semiconductor Q3 Adjusted Earnings, Revenue Rise; Q4 Outlook Set
Nov 3, 2025
04:18 PM EST, 11/03/2025 (MT Newswires) -- Lattice Semiconductor ( LSCC ) reported Q3 adjusted earnings late Monday of $0.28 per diluted share, up from $0.24 a year earlier. Analysts polled by FactSet expected $0.28. Revenue for the three months ended Sept. 27 was $133.3 million, up from $127.1 million a year earlier. Analysts surveyed by FactSet expected $133 million....
Vertex beats quarterly estimates on cystic fibrosis demand, new drugs
Vertex beats quarterly estimates on cystic fibrosis demand, new drugs
Nov 3, 2025
Nov 3 (Reuters) - Vertex Pharmaceuticals ( VRTX ) reported on Monday that it beat Wall Street estimates for third-quarter results, driven by strong demand for its cystic fibrosis treatments and early contributions from newer medicines. The Boston-based company reported total revenue of $3.08 billion for the quarter ended September 30, above analysts' average estimate of $3.05 billion, according to...
Hims and Hers beats revenue estimates on strong subscriber growth
Hims and Hers beats revenue estimates on strong subscriber growth
Nov 3, 2025
(Reuters) -Hims and Hers Health ( HIMS ) beat Wall Street estimates for third-quarter revenue on Monday, as the telehealth company added subscribers and expanded its personalized healthcare offerings. The company and rivals have launched programs that offer personalized versions of semaglutide, the active ingredient in weight-loss drug Wegovy, at doses not accessible through the branded manufacturers, following the government's...
Playstudios misses Q3 revenue estimates on softness in casino business 
Playstudios misses Q3 revenue estimates on softness in casino business 
Nov 3, 2025
Overview * Playstudios ( MYPS ) Q3 revenue of $57.6 mln missed analyst expectations * Net loss for Q3 widened to $9.1 mln from $3.1 mln last year * Direct-to-consumer revenue increased by 48% yr/yr in Q3 Outlook * Company expects full-year revenue and AEBITDA below previous guidance due to player activity softness * Company focuses on direct-to-consumer growth and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved